What does THRT mean in NASDAQ SYMBOLS
THRT stands for Theratech, Incorporated, a former biopharmaceutical company in Utah. The company was listed on the NASDAQ Stock Exchange until 2002. This organization focused on developing and manufacturing therapeutic treatments that could be used to treat diseases such as infectious diseases, cancer, and chronic illnesses. THRT also worked to develop therapies for conditions related to aging, such as age-related macular degeneration and cataracts.
THRT meaning in NASDAQ Symbols in Business
THRT mostly used in an acronym NASDAQ Symbols in Category Business that means Theratech, Incorporated, of Utah (de-listed)
Shorthand: THRT,
Full Form: Theratech, Incorporated, of Utah (de-listed)
For more information of "Theratech, Incorporated, of Utah (de-listed)", see the section below.
Focus of the Company
As a biopharmaceutical research and development company, THRT sought to discover innovative treatments for diseases by utilizing gene-based technology combined with traditional drug discovery methods. Through its efforts, THRT hoped to improve people's quality of life while reducing healthcare costs associated with chronic illnesses and other medical conditions. It also worked to increase patient access to effective therapies through new drug formulations.
Types of Treatments Developed by THRT
Theratech developed several different types of treatments during its time in business. These included small molecule drugs designed to target receptors in the brain or other organs that cause disease; monoclonal antibodies used for targeting specific proteins that potentially contribute to diseases; vaccine technologies aimed at preventing or treating viral or bacterial infection; gene transfer technology focused on altering cell behavior; gene replacement therapy intended for treating various genetic disorders; and stem cell research intended for rehabilitation and regenerative medicine.
Products Developed by THRT
During its years in business, Theratech developed products in each of these focus areas including Leustatin (an anti-cancer drug), Pleconaril (a small molecule antiviral drug) and an oral insulin product known as Meticulin though it never made it into clinical trials. The company also conducted research into gene therapy approaches, such as using viral vectors to introduce genes into cells within the body, which is a form of treatment still being explored today.
Essential Questions and Answers on Theratech, Incorporated, of Utah (de-listed) in "BUSINESS»NASDAQ"
Though no longer operating today, Theratech was once one of the leading organizations pursuing innovative therapeutic treatments through gene-based technologies when it was active in the late 1990s and early 2000s. The company's pioneering work inspired many others in the field since then, furthering our understanding of how we can use genetic technology both for research purposes as well as practical therapies available now or soon in the future.